Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000930413-25-003473·Clearmind Medicine Inc.
Schedule 13G ownership disclosure
CLEARMIND MEDICINE INC
Common Stock, no par value · CUSIP: 185053402
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Iroquois Capital Management, LLC
Shares: 310,990.00 · Class: 5.38%
- Richard Abbe
Shares: 603,470.00 · Class: 9.94%
- Kimberly Page
Shares: 310,990.00 · Class: 5.38%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-25-003473
- Form type
- SCHEDULE 13G/A
- Filer
- Clearmind Medicine Inc.
- CIK
- CIK 1892500
- Filed
- Nov 18, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership